Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease Popular weight loss medications such as semaglutide and tirzepatide are associated with multiple benefits for patients with moderate peripheral artery disease (PAD), according to new data presented at the Society for Vascular Surgerys annual meeting in New Orleans
Mice with intestinal deletion of SIRT1 have been shown to exhibit microbiota dysbiosis and aberrant activation of the inflammatory response (Wellman et al
NICE guidance recognises that maintaining weight loss is itself a significant clinical achievement, as most individuals regain weight after stopping obesity treatments
These models have provided crucial insights into the immunological pathways that drive autoimmune thyroid diseases and have been essential for developing potential immunomodulatory therapies aimed at modulating the autoimmune response in Hashimotos thyroiditis (Qian et al
Could Ozempic and Other GLP-1 Drugs Treat Alcohol Use Disorder
The capsules are small, which is great, and the dosage does not complicate our daily schedule
